TNM cancer staging: can it help develop a novel staging system for type 2 diabetes?
Moahad S Dar,1,2 Sami A Bég3 1Department of Veteran Affairs, Greenville Health Care Center, Greenville, NC, USA; 2Division of Endocrinology & Metabolism, Department of Internal Medicine, Brody School of Medicine at East Carolina University, Greenville, NC, USA; 3Proactive Living I...
Saved in:
Main Authors: | Dar MS, Bég SA |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2018
|
Subjects: | |
Online Access: | https://doaj.org/article/84f3a2ee9dde4d4e8aa6c2d1866341f7 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Metabolic and Energy Imbalance in Dysglycemia-Based Chronic Disease
by: Kalra S, et al.
Published: (2021) -
Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
by: Hu Y, et al.
Published: (2021) -
Clinical Significance of Non-invasive Skin Autofluorescence Measurement in Patients with Diabetes: A Systematic Review and Meta-analysis
by: Mahboobeh sadat Hosseini, MD, et al.
Published: (2021) -
Platelet Indices and Its Association with Microvascular Complications Among Type 2 Diabetes Mellitus Patients in Northeast Ethiopia: A Cross-Sectional Study
by: Taderegew MM, et al.
Published: (2021) -
Second line therapy in type 2 diabetes: legacy effect activation
by: Ekaterina A. Shestakova
Published: (2017)